NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 96 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11 | -57.7% | 10,272 | +1.2% | 0.00% | – |
| Q2 2023 | $26 | -36.6% | 10,146 | 0.0% | 0.00% | – |
| Q1 2023 | $41 | -69.2% | 10,146 | -61.6% | 0.00% | – |
| Q4 2022 | $133 | -100.0% | 26,446 | -0.1% | 0.00% | -100.0% |
| Q3 2022 | $346,000 | +18.9% | 26,462 | +16.5% | 0.00% | – |
| Q2 2022 | $291,000 | -16.1% | 22,710 | -0.3% | 0.00% | – |
| Q1 2022 | $347,000 | -13.9% | 22,784 | +0.1% | 0.00% | – |
| Q4 2021 | $403,000 | -16.2% | 22,764 | -0.5% | 0.00% | -100.0% |
| Q3 2021 | $481,000 | -10.4% | 22,872 | -15.9% | 0.00% | 0.0% |
| Q2 2021 | $537,000 | -16.1% | 27,207 | +23.7% | 0.00% | 0.0% |
| Q1 2021 | $640,000 | -3.9% | 22,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $666,000 | +90.3% | 22,000 | 0.0% | 0.00% | – |
| Q3 2020 | $350,000 | -19.4% | 22,000 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $434,000 | +60.1% | 22,000 | 0.0% | 0.00% | – |
| Q1 2020 | $271,000 | -33.4% | 22,000 | 0.0% | 0.00% | – |
| Q4 2019 | $407,000 | +324.0% | 22,000 | +218.8% | 0.00% | – |
| Q3 2019 | $96,000 | -5.0% | 6,900 | 0.0% | 0.00% | – |
| Q2 2019 | $101,000 | – | 6,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenspring Associates, LLC | 1,573,357 | $47,665,000 | 61.89% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $114,111,000 | 60.06% |
| Column Group LLC | 15,396,116 | $466,502,000 | 42.31% |
| Ponoi II Management, LLC | 1,298,908 | $39,357,000 | 28.68% |
| Ponoi Management, LLC | 1,298,908 | $39,357,000 | 22.52% |
| Euclidean Capital LLC | 2,083,602 | $63,133,000 | 13.36% |
| Aquilo Capital Management, LLC | 1,005,534 | $30,463,000 | 6.33% |
| Octagon Capital Advisors LP | 75,227 | $2,279,000 | 0.79% |
| Jasper Ridge Partners, L.P. | 308,750 | $9,354,000 | 0.41% |
| Point72 Asset Management, L.P. | 1,761,157 | $53,354,000 | 0.26% |